Back to search

Article

Reporting amyloid beta levels <i>via</i> bioluminescence imaging with amyloid reservoirs in Alzheimer’s disease models

2021-06-07

Abstract excerpt

Bioluminescence imaging has changed daily practice in preclinical research of cancers and other diseases in the last decades; however, it has been rarely applied in preclinical research of Alzheimer’s disease (AD). In this report, we demonstrated that bioluminescence imaging could be used to report the levels of amyloid beta (Aβ) species in vivo. We hypothesized that AkaLumine, a newly discovered substrate for luc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b1307220-6a8e-59b3-a3f9-1ffca4d4fbe6
DOI
10.1101/2021.06.05.447217
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Reporting amyloid beta levels <i>via</i> bioluminescence imaging with amyloid reservoirs in Alzheimer’s disease modelsDOI 10.1101/2021.06.05.447217
Select a neighboring publication to make it the new centre.